• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach.

作者信息

Verdonschot Job A J, Hazebroek Mark R, Ware James S, Prasad Sanjay K, Heymans Stephane R B

机构信息

Department of Cardiology CARIM Maastricht University Medical Centre Maastricht The Netherlands.

Department of Clinical Genetics Maastricht University Medical Centre Maastricht The Netherlands.

出版信息

J Am Heart Assoc. 2019 Jun 4;8(11):e012514. doi: 10.1161/JAHA.119.012514. Epub 2019 Jun 1.

DOI:10.1161/JAHA.119.012514
PMID:31433726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6585365/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e5b/6585365/5941bc319380/JAH3-8-e012514-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e5b/6585365/8d655139629a/JAH3-8-e012514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e5b/6585365/4ca8ea5082e2/JAH3-8-e012514-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e5b/6585365/5941bc319380/JAH3-8-e012514-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e5b/6585365/8d655139629a/JAH3-8-e012514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e5b/6585365/4ca8ea5082e2/JAH3-8-e012514-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e5b/6585365/5941bc319380/JAH3-8-e012514-g003.jpg

相似文献

1
Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach.靶向治疗在扩张型心肌病中的作用：迈向个性化治疗方法的艰难之路。
J Am Heart Assoc. 2019 Jun 4;8(11):e012514. doi: 10.1161/JAHA.119.012514. Epub 2019 Jun 1.
2
Role of titin in cardiomyopathy: from DNA variants to patient stratification.肌联蛋白在心肌病中的作用：从 DNA 变异到患者分层。
Nat Rev Cardiol. 2018 Apr;15(4):241-252. doi: 10.1038/nrcardio.2017.190. Epub 2017 Dec 14.
3
The natural history of acute dilated cardiomyopathy.急性扩张型心肌病的自然病史。
Trans Am Clin Climatol Assoc. 2014;125:76-86; discussion 86-7.
4
[Dilated cardiomyopathy--diagnosis and conservative therapy].
Acta Med Austriaca. 1995;22(5):90-3.
5
Precision Medicine in the Management of Dilated Cardiomyopathy: JACC State-of-the-Art Review.精准医疗在扩张型心肌病管理中的应用：美国心脏病学会的最新综述。
J Am Coll Cardiol. 2019 Dec 10;74(23):2921-2938. doi: 10.1016/j.jacc.2019.10.011.
6
Dilated cardiomyopathy.扩张型心肌病
Circ Arrhythm Electrophysiol. 2013 Feb;6(1):228-37. doi: 10.1161/CIRCEP.111.962050. Epub 2012 Sep 28.
7
[Dilated cardiomyopathy and myocarditis. Current diagnostic requirements and therapeutic possibilities].[扩张型心肌病与心肌炎。当前的诊断要求及治疗可能性]
Internist (Berl). 2002 Apr;43 Suppl 1:S45-6, S49-65. doi: 10.1007/s00108-002-0590-0.
8
Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.遗传性心肌病的进展：扩张型、肥厚型和致心律失常性右室发育不良/心肌病的筛查、咨询与检测
Circ Heart Fail. 2009 May;2(3):253-61. doi: 10.1161/CIRCHEARTFAILURE.108.817346.
9
The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy.扩张型心肌病分子遗传学检测的原理与时机
Can J Cardiol. 2015 Nov;31(11):1309-12. doi: 10.1016/j.cjca.2015.06.034. Epub 2015 Jul 9.
10
Peripartum cardiomyopathy-diagnosis, management, and long term implications.围生期心肌病-诊断、治疗及长期影响。
Trends Cardiovasc Med. 2019 Apr;29(3):164-173. doi: 10.1016/j.tcm.2018.07.012. Epub 2018 Aug 1.

引用本文的文献

1
Cardiomyopathy: pathogenesis and therapeutic interventions.心肌病：发病机制与治疗干预措施
MedComm (2020). 2024 Oct 25;5(11):e772. doi: 10.1002/mco2.772. eCollection 2024 Nov.
2
The emerging role of clonal haematopoiesis in the pathogenesis of dilated cardiomyopathy.克隆性造血在扩张型心肌病发病机制中的新作用。
Eur Heart J. 2024 Oct 17;45(45):4797-807. doi: 10.1093/eurheartj/ehae682.
3
Personalized transcriptome signatures in a cardiomyopathy stem cell biobank.心肌病干细胞生物样本库中的个性化转录组特征

本文引用的文献

1
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure.卡那奴单抗的抗炎治疗预防心力衰竭住院。
Circulation. 2019 Mar 5;139(10):1289-1299. doi: 10.1161/CIRCULATIONAHA.118.038010.
2
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.恢复性扩张型心肌病患者停止心力衰竭的药物治疗（TRED-HF）：一项开放标签、先导、随机试验。
Lancet. 2019 Jan 5;393(10166):61-73. doi: 10.1016/S0140-6736(18)32484-X. Epub 2018 Nov 11.
3
Heart Failure With Recovered Ejection Fraction.
bioRxiv. 2024 May 14:2024.05.10.593618. doi: 10.1101/2024.05.10.593618.
4
Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift?扩张型心肌病的精准治疗：空想还是范式转变？
Camb Prism Precis Med. 2023 Nov 20;1:e34. doi: 10.1017/pcm.2023.24. eCollection 2023.
5
Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal Study.胶原蛋白代谢生物标志物与扩张型心肌病的左心室功能及预后相关：一项多模态研究
J Clin Med. 2023 Sep 1;12(17):5695. doi: 10.3390/jcm12175695.
6
Mislocalization of pathogenic RBM20 variants in dilated cardiomyopathy is caused by loss-of-interaction with Transportin-3.致病性 RBM20 变异体在扩张型心肌病中的定位错误是由于与 Transportin-3 相互作用丧失所致。
Nat Commun. 2023 Jul 18;14(1):4312. doi: 10.1038/s41467-023-39965-6.
7
Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy.成人起病型遗传性扩张型心肌病中的心脏炎症
J Clin Med. 2023 Jun 9;12(12):3937. doi: 10.3390/jcm12123937.
8
Striated muscle-specific base editing enables correction of mutations causing dilated cardiomyopathy.横纹肌特异性碱基编辑可纠正导致扩张型心肌病的突变。
Nat Commun. 2023 Jun 22;14(1):3714. doi: 10.1038/s41467-023-39352-1.
9
Clustering of Cardiac Transcriptome Profiles Reveals Unique: Subgroups of Dilated Cardiomyopathy Patients.心脏转录组图谱聚类揭示扩张型心肌病患者的独特亚组
JACC Basic Transl Sci. 2023 Feb 1;8(4):406-418. doi: 10.1016/j.jacbts.2022.10.010. eCollection 2023 Apr.
10
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) in Cardiovascular Disease: A Comprehensive Clinical Review on Dilated Cardiomyopathy.心血管疾病中的成簇规律间隔短回文重复序列（CRISPR）：关于扩张型心肌病的综合临床综述
Cureus. 2023 Mar 5;15(3):e35774. doi: 10.7759/cureus.35774. eCollection 2023 Mar.
射血分数恢复的心力衰竭
J Am Coll Cardiol. 2018 Sep 25;72(13):1557-1558. doi: 10.1016/j.jacc.2018.06.070.
4
Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement.扩张型心肌病的转归与晚期钆增强的范围、部位和模式有关。
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1645-1655. doi: 10.1016/j.jcmg.2018.07.015. Epub 2018 Sep 12.
5
Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.利用 CRISPR/Cas9 和人诱导多能干细胞确定不确定意义的基因组变异的致病性。
Circulation. 2018 Dec 4;138(23):2666-2681. doi: 10.1161/CIRCULATIONAHA.117.032273.
6
Genetic Etiology for Alcohol-Induced Cardiac Toxicity.酒精性心脏毒性的遗传病因学。
J Am Coll Cardiol. 2018 May 22;71(20):2293-2302. doi: 10.1016/j.jacc.2018.03.462.
7
Meta-analysis of trimetazidine treatment for cardiomyopathy.曲美他嗪治疗心肌病的荟萃分析。
Biosci Rep. 2018 Jun 12;38(3). doi: 10.1042/BSR20171583. Print 2018 Jun 29.
8
Catalyzing the field of precision oncology, one basket at a time.一次推动一个领域，催化精准肿瘤学领域的发展。
Nat Med. 2018 Apr 10;24(4):387-388. doi: 10.1038/nm.4530.
9
Immunosuppressive Therapy Improves Both Short- and Long-Term Prognosis in Patients With Virus-Negative Nonfulminant Inflammatory Cardiomyopathy.免疫抑制疗法改善病毒阴性非暴发性炎症性心肌病患者的短期和长期预后。
Circ Heart Fail. 2018 Feb;11(2):e004228. doi: 10.1161/CIRCHEARTFAILURE.117.004228.
10
Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins.表达病理性核纤层蛋白的心肌细胞的生物力学缺陷和挽救。
Cardiovasc Res. 2018 May 1;114(6):846-857. doi: 10.1093/cvr/cvy040.